CRITICAL PATH INSTITUTE: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- CRITICAL PATH INSTITUTE (EIN 20-1991334)
- Tax period
- 2022-07-01 to 2023-06-30
- Filed
- 2024-03-20
- IRS object ID
- 202410809349300526
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-03-20T10:40:10-05:00 | ReturnTs |
| Tax Period End | 2023-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 860683059 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BEACHFLEISCHMAN PLLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1985 E RIVER ROAD SUITE 201 | AddressLine1Txt |
| City | TUCSON | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85718 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 201991334 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CRITICAL PATH INSTITUTE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | CRIT | BusinessNameControlTxt |
| Phone | 5205473440 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1840 E RIVER ROAD 100 | AddressLine1Txt |
| City | TUCSON | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85718 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | KEVIN B PERKINS | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 5205473440 | PhoneNum |
| Signature | 2024-03-18 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | KEVIN | PersonFirstNm |
| Person Last | PERKINS | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | KELLY L MELTZER CPA | PreparerPersonNm |
| PTIN | P00633511 | PTIN |
| Phone | 5203214600 | PhoneNum |
| Preparation | 2024-03-18 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | DR KLAUS ROMERO | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1840 E RIVER ROAD 100 | AddressLine1Txt |
| City | TUCSON | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85718 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $35,267,282 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | C-PATH.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2004 | FormationYr |
| Legal Domicile State | AZ | LegalDomicileStateCd |
| Activity Or Mission | INTERNATIONAL COLLABORATIONS AND NOVEL TOOLS TO ENABLE FASTER DEVELOPMENT OF SAFE MEDICAL PRODUCTS | ActivityOrMissionDesc |
| Voting Members Governing Body | 13 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 13 | VotingMembersIndependentCnt |
| Total Employee | 176 | TotalEmployeeCnt |
| Total Volunteers | 13 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $23,061,454 | PYContributionsGrantsAmt |
| CY Contributions Grants | $23,557,036 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $8,108,029 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $11,292,408 | CYProgramServiceRevenueAmt |
| PY Investment Income | $6,633 | PYInvestmentIncomeAmt |
| CY Investment Income | $403,834 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $14,004 | CYOtherRevenueAmt |
| PY Total Revenue | $31,176,116 | PYTotalRevenueAmt |
| CY Total Revenue | $35,267,282 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $4,230,463 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $4,623,204 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $17,392,416 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $19,471,313 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $7,977,401 | PYOtherExpensesAmt |
| CY Other Expenses | $7,913,861 | CYOtherExpensesAmt |
| PY Total Expenses | $29,600,280 | PYTotalExpensesAmt |
| CY Total Expenses | $32,008,378 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $1,575,836 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $3,258,904 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $19,962,086 | TotalAssetsBOYAmt |
| Total Assets EOY | $26,726,645 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $7,937,546 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $11,460,775 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $12,024,540 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $15,265,870 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE CRITICAL PATH INSTITUTE IS A CATALYST IN THE DEVELOPMENT OF NEW APPROACHES THAT ADVANCE MEDICAL INNOVATION AND REGULATORY SCIENCE. THIS IS ACHIEVED BY LEADING TEAMS THAT SHARE DATA, KNOWLEDGE AND EXPERTISE RESULTING IN SOUND, CONSENSUS BASED SCIENCE. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $5,965,204 | ExpenseAmt |
| Grant | $1,517,664 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | RARE DISEASE CURES ACCELERATOR-DATA AND ANALYTICS PLATFORM (RDCA-DAP) - SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $4,448,188 | ExpenseAmt |
| Grant | $2,402,563 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | CURE DRUG REPURPOSING COLLABORATORY (CDRC) - SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $2,471,751 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | CRITICAL PATH FOR RARE NEURODEGENERATIVE DISEASES (CP-RND) - SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $13,336,642 | ExpenseAmt |
| Grant | $702,977 | GrantAmt |
| Revenue | $11,306,412 | RevenueAmt |
| Desc | CRITICAL PATH INSTITUTE ALSO EXECUTES OTHER PROJECTS AND CONSORTIA IN AREAS INCLUDING THERAPEUTICS FOR THE ATAXIAS, POLYCYSTIC KIDNEY DISORDER, ALZHEIMER'S DISEASE, PARKINSON'S, TB, SICKLE CELL DISEASE, TYPE 1 DIABETES, DUCHENNE MUSCULAR DYSTROPHY, ALPHA-1 ANTITRYPSIN DEFICIENCY, LYSOSOMAL DISEASES, MODEL INFORMED DRUG DEVELOPMENT, PATIENT-REPORTED OUTCOME, ELECTRONIC CLINICAL OUTCOME ASSESSMENT, RARE DISEASE CLINICAL OUTCOME ASSESSMENT, TRANSPLANT THERAPEUTICS, PREDICTIVE SAFETY TESTING, PEDIATRICS, AND OTHERS. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $13,336,642 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $702,977 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $11,306,412 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $26,221,785 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (1) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | Yes (1) | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (1) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 40 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 176 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (1) | ForeignFinancialAccountInd |
| Foreign Country | EI | ForeignCountryCd |
| Foreign Country | NL | ForeignCountryCd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 13 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 13 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KEVIN B PERKINS CFO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 5205473440 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1840 E RIVER ROAD 100 | AddressLine1Txt |
| City | TUCSON | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85718 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (27 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd |
|---|---|---|---|---|---|---|---|---|
| MS KRISTEN SWINGLE | ||||||||
| COO & PRESIDENT | 40.00 | Yes (X) | $310,147 | $0 | $46,318 | |||
| DR KLAUS ROMERO | ||||||||
| CHIEF SCIENCE OFFICER | 40.00 | $241,799 | $0 | $34,990 | Yes (X) | |||
| MR KEVIN PERKINS | ||||||||
| CHIEF FINANCIAL OFFICER & TREASURER | 40.00 | Yes (X) | $236,942 | $0 | $47,814 | |||
| MR RICHARD LIWSKI | ||||||||
| CHIEF TECHNOLOGY OFFICER | 40.00 | $226,150 | $0 | $29,603 | Yes (X) | |||
| DR STEPHEN COONS | ||||||||
| SENIOR VICE PRESIDENT THRU 03/31/23 | 40.00 | $224,167 | $0 | $28,959 | Yes (X) | |||
| DR SUDHIR SIVAKUMARAN | ||||||||
| VICE PRESIDENT/EXECUTIVE DIRECTOR | 40.00 | $208,819 | $0 | $39,798 | Yes (X) | |||
| DR DIANE STEPHENSON | ||||||||
| EXECUTIVE DIRECTOR | 40.00 | $194,282 | $0 | $30,675 | Yes (X) | |||
| DR SERGEY RAKHILIN | ||||||||
| EXECUTIVE DIRECTOR | 40.00 | $190,374 | $0 | $12,440 | Yes (X) | |||
| MS SONYA EREMENCO | ||||||||
| EXECUTIVE DIRECTOR | 40.00 | $190,367 | $0 | $27,355 | Yes (X) | |||
| DR MARCO SCHITO | ||||||||
| EXECUTIVE DIRECTOR | 40.00 | $182,025 | $0 | $29,782 | Yes (X) | |||
| MS TERINA MARTINEZ | ||||||||
| EXECUTIVE DIRECTOR | 40.00 | $182,013 | $0 | $21,789 | Yes (X) | |||
| DR KANWALJIT SINGH | ||||||||
| EXECUTIVE DIRECTOR | 40.00 | $178,413 | $0 | $34,960 | Yes (X) | |||
| MR NICHOLAS KING | ||||||||
| EXECUTIVE DIRECTOR | 40.00 | $173,081 | $0 | $24,543 | Yes (X) | |||
| MR LEWIS BARBIERI | ||||||||
| CORPORATE SECRETARY | 40.00 | Yes (X) | $134,433 | $0 | $24,011 | |||
| MR DANIEL M JORGENSEN | ||||||||
| CEO/BOARD MEMBER | 40.00 | Yes (X) | $100,075 | $0 | $8,047 | Yes (X) | ||
| MR M WAINWRIGHT FISHBURN JR | ||||||||
| CHAIRMAN | 1.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| MR JEFFERY JACOB | ||||||||
| VICE CHAIRMAN | 1.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| MR ALAN G LEVIN | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| MR JAMES W NEWMAN | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| DR KAREN BERNSTEIN | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| MS KAY HOLCOMBE | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| MS MARA G ASPINALL | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| DR PAULA J OLSIEWSKI | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| MR PETER BARTON HUTT | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| MR SHAUN A KIRKPATRICK | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| DR TIMOTHY R FRANSON | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| DR TOMAS SALMONSON | ||||||||
| BOARD MEMBER | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,973,087 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $441,084 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 60 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | CountryContractorAddress/ForeignAddress/CountryCd | ServicesServicesDesc | CompensationCompensationAmt | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd | Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd |
|---|---|---|---|---|---|---|---|---|---|---|
| ARIDHIA INFORMATICS LIMITED | ||||||||||
| 163 BATH STREET | GLASGOW | UK | IT SERVICES | $726,962 | ||||||
| REPLICA ANALYTICS LTD | ||||||||||
| 150 ELGIN STREET FLOOR 10 | OTTAWA | CA | CONSULTANT | $297,070 | ONTARIO | K2P 1L4 | ||||
| LOTOS NILE | ||||||||||
| PUBLIC RELATIONS | $254,344 | PO BOX 90245 | NASHVILLE | TN | 37209 | |||||
| PHARMASCOUTS | ||||||||||
| CONSULTANT | $174,000 | 5580 LA JOLLA BOULEVARD 17 | LA JOLLA | CA | 92037 | |||||
| MARYNA KOLOCHAVINA | ||||||||||
| NEHRINGSTR 33 | BERLIN | GM | CONSULTANT | $166,988 | ||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 7 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $18,935,171 | GovernmentGrantsAmt |
| All Other Contributions | $4,621,865 | AllOtherContributionsAmt |
| Noncash Contributions | $32,192 | NoncashContributionsAmt |
| Total Contributions | $23,557,036 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| RESEARCH SUPPORT FEES | 541700 | $11,161,610 | $11,161,610 |
| OTHER REVENUE | 900099 | $130,798 | $130,798 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $11,292,408 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $403,834 | TotalRevenueColumnAmt |
| Exclusion | $403,834 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | EARNINGS FROM SUBSIDIARY | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $14,004 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $14,004 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $14,004 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $35,267,282 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $11,306,412 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $403,834 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,116,598 | TotalAmt |
| Program Services | $4,116,598 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $506,606 | TotalAmt |
| Program Services | $506,606 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,549,216 | TotalAmt |
| Program Services | $1,421,459 | ProgramServicesAmt |
| Management And General | $1,127,757 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,659,070 | TotalAmt |
| Program Services | $11,979,800 | ProgramServicesAmt |
| Management And General | $1,679,270 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $950,723 | TotalAmt |
| Program Services | $843,492 | ProgramServicesAmt |
| Management And General | $107,231 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,186,216 | TotalAmt |
| Program Services | $1,022,677 | ProgramServicesAmt |
| Management And General | $163,539 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,126,088 | TotalAmt |
| Program Services | $940,449 | ProgramServicesAmt |
| Management And General | $185,639 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $52,818 | TotalAmt |
| Program Services | $512 | ProgramServicesAmt |
| Management And General | $52,306 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $71,025 | TotalAmt |
| Management And General | $71,025 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,758,957 | TotalAmt |
| Program Services | $2,325,857 | ProgramServicesAmt |
| Management And General | $433,100 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $329,465 | TotalAmt |
| Program Services | $44,352 | ProgramServicesAmt |
| Management And General | $285,113 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $347,789 | TotalAmt |
| Program Services | $22,828 | ProgramServicesAmt |
| Management And General | $324,961 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,756,423 | TotalAmt |
| Program Services | $1,152,812 | ProgramServicesAmt |
| Management And General | $603,611 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $526,615 | TotalAmt |
| Program Services | $419,541 | ProgramServicesAmt |
| Management And General | $107,074 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $698,989 | TotalAmt |
| Program Services | $535,732 | ProgramServicesAmt |
| Management And General | $163,257 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,070,950 | TotalAmt |
| Program Services | $794,698 | ProgramServicesAmt |
| Management And General | $276,252 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $30,852 | TotalAmt |
| Program Services | $4,806 | ProgramServicesAmt |
| Management And General | $26,046 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $102,970 | TotalAmt |
| Management And General | $102,970 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (2 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| DUES AND SUBSCRIPTIONS | $101,097 | $35,965 | $65,132 |
| MISCELLANEOUS | $65,911 | $53,601 | $12,310 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $32,008,378 | TotalAmt |
| Program Services | $26,221,785 | ProgramServicesAmt |
| Management And General | $5,786,593 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,618,376 | BOYAmt |
| EOY | $1,343,137 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,932,086 | BOYAmt |
| EOY | $18,603,787 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,336,559 | BOYAmt |
| EOY | $2,673,874 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $804,595 | BOYAmt |
| EOY | $1,595,768 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $46,337 | BOYAmt |
| EOY | $100,962 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $209,808 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $168,068 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $72,592 | BOYAmt |
| EOY | $41,740 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $151,541 | BOYAmt |
| EOY | $2,367,377 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,962,086 | BOYAmt |
| EOY | $26,726,645 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,958,777 | BOYAmt |
| EOY | $2,558,542 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,896,296 | BOYAmt |
| EOY | $6,796,932 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $82,473 | BOYAmt |
| EOY | $2,105,301 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,937,546 | BOYAmt |
| EOY | $11,460,775 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,024,540 | BOYAmt |
| EOY | $15,265,870 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,024,540 | BOYAmt |
| EOY | $15,265,870 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,962,086 | BOYAmt |
| EOY | $26,726,645 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $3,258,904 | ReconcilationRevenueExpnssAmt |
| Other Changes In Net Assets | -$17,574 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $10,698,823 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $12,978,641 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $17,810,315 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $23,061,454 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $23,557,036 | CurrentTaxYearAmt |
| Total | $88,106,269 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $10,698,823 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $12,978,641 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $17,810,315 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $23,061,454 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $23,557,036 | CurrentTaxYearAmt |
| Total | $88,106,269 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $8,653,378 | SubstantialContributorsTotAmt |
| Public Support Total170 | $79,452,891 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $215,046 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $156,753 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $5,817 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $6,633 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $403,834 | CurrentTaxYearAmt |
| Total | $788,083 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $88,894,352 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $37,238,127 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.89380 | PublicSupportCY170Pct |
| Public Support PY170 | 0.83360 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Total Grassroots Lobbying TotalGrassrootsLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $32,008,378 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $32,008,378 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,000,000 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $250,000 | FilingOrganizationsTotalAmt |
Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,000,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $1,000,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $1,000,000 | CurrentYearMinus1Amt |
| Current Year | $1,000,000 | CurrentYearAmt |
| Total | $4,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $250,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $250,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $250,000 | CurrentYearMinus1Amt |
| Current Year | $250,000 | CurrentYearAmt |
| Total | $1,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-A, LINE 1B | FormAndLineReferenceDesc |
| Explanation | C-PATH DOES NOT LOBBY FOR OR AGAINST ANY SPECIFIC LEGISLATION. C-PATH DOES EXPEND A MODEST AMOUNT OF TIME AND MONEY TO EDUCATE LEGISLATORS AND THEIR STAFF IN THE AREA OF DRUG DEVELOPMENT. | ExplanationTxt |
Schedule D IRS990ScheduleD
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $34,898 | OtherCostOrOtherBasisAmt |
| Depreciation | $34,898 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $19,837 | OtherCostOrOtherBasisAmt |
| Depreciation | $16,434 | DepreciationAmt |
| Book Value | $3,403 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $155,073 | OtherCostOrOtherBasisAmt |
| Depreciation | $116,736 | DepreciationAmt |
| Book Value | $38,337 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $41,740 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp (5 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| DEPOSITS | $12,673 |
| DUE FROM AFFILIATE | $149,012 |
| INVESTMENT IN SUBSIDIARY | -$748 |
| OTHER RECEIVABLES | $122,204 |
| OPERATING LEASE ASSETS | $2,084,236 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $2,367,377 | TotalBookValueOtherAssetsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | OPERATING LEASE OBLIGATIONS | Desc |
| Amt | $2,105,301 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $2,105,301 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | FINANCIAL STATEMENT FIN 48 (ASC 740) FOOTNOTE: C-PATH IS EXEMPT FROM INCOME TAXES UNDER BOTH FEDERAL (INTERNAL REVENUE CODE SECTION 501(C)(3)) AND ARIZONA INCOME TAX LAWS, AND IS CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION UNDER INTERNAL REVENUE CODE SECTION 509(A)(1). INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO C-PATH'S TAX-EXEMPT PURPOSE, HOWEVER, MAY BE SUBJECT TO TAXATION AS UNRELATED BUSINESS TAXABLE INCOME. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| NORTH AMERICA (CANADA) | 0 | 0 | BUSINESS/VENDOR SERVICES | IT SERVICES, CONSULTING | $338,146 |
| EUROPE (IRELAND, NETHERLANDS, SWEDEN, SWITZERLAND) | 0 | 7 | BUSINESS/VENDOR SERVICES | IT SERVICES, CONSULTING, LICENSING, PAYROLL SERVICES | $460,651 |
| EUROPE (UNITED KINGDOM) | 0 | 1 | GRANTS TO RECIPIENTS LOCATED IN REGION | CLINICAL RESEARCH | $506,606 |
| EUROPE (FRANCE, GERMANY, SLOVENIA, SWEDEN, UNITED KINGDOM) | 0 | 0 | PROGRAM SERVICES/BUSINESS SERVICES | CLINICAL RESEARCH, CONSULTING, FILING FEES, EVENTS | $1,066,452 |
| EUROPE (IRELAND, NETHERLANDS, SWEDEN, SWITZERLAND) | 0 | 0 | INVESMENT | -$748 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 8 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 8 | TotalEmployeeCnt |
| Subtotal Spent | $2,371,107 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $2,371,107 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | RegionTxt |
| Purpose Of Grant | SUBAWARD | PurposeOfGrantTxt |
| Cash Grant | $506,606 | CashGrantAmt |
| Manner Of Cash Disbursement | WIRE TRANSFER | MannerOfCashDisbursementTxt |
| Non Cash Assistance | $0 | NonCashAssistanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | Yes (1) | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (1) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | CRITICAL PATH INSTITUTE ENTERS INTO SUBAWARD AGREEMENTS WITH SUBRECIPIENTS AND REVIEWS PROGRESS DELIVERABLES AND COSTS. |
| PART III ACCOUNTING METHOD: |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (12 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD) | ||||||||
| 1900 CROWN COLONY DRIVE SUITE 310 | QUINCY | MA | 02169 | 133223946 | 501(C)(3) | $1,517,664 | $0 | SUBAWARD |
| JAEB CENTER FOR HEALTH RESEARCH | ||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | 593187624 | 501(C)(3) | $14,789 | $0 | SUBAWARD |
| TUFTS MEDICAL CENTER INC | ||||||||
| 800 WASHINGTON STREET RF BOX 453 | BOSTON | MA | 02111 | 043400617 | 501(C)(3) | $86,009 | $0 | SUBAWARD |
| INSTITUTE FOR ADVANCED CLINICAL TRIALS FOR CHILDREN | ||||||||
| 9211 CORPORATE BOULEVARD SUITE 260 | ROCKVILLE | MD | 20850 | 812076517 | 501(C)(3) | $77,657 | $0 | SUBAWARD |
| NORTHWESTERN UNIVERSITY | ||||||||
| 633 CLARK STREET ROOM G-547 | EVANSTON | IL | 60208 | 362167817 | 501(C)(3) | $54,297 | $0 | SUBAWARD |
| SOCIETY OF CRITICAL CARE MEDICINE | ||||||||
| 35083 EAGLE WAY | CHICAGO | IL | 60678 | 237104387 | 501(C)(3) | $1,377,667 | $0 | SUBAWARD |
| JOHNS HOPKINS UNIVERSITY | ||||||||
| 12529 COLLECTIONS CENTER DRIVE | CHICAGO | IL | 60693 | 520595110 | 501(C)(3) | $480,752 | $0 | SUBAWARD |
| EMORY UNIVERSITY | ||||||||
| 1599 CLIFTON ROAD NE 4TH FLOOR | ATLANTA | GA | 30322 | 580566256 | 501(C)(3) | $160,714 | $0 | SUBAWARD |
| UNIVERSITY OF ROCHESTER | ||||||||
| 265 CRITTENDEN BOULEVARD CU420694 | ROCHESTER | NY | 14642 | 160743209 | 501(C)(3) | $89,728 | $0 | SUBAWARD |
| YALE UNIVERSITY | ||||||||
| 150 MUNSON STREET 3RD FLOOR | NEW HAVEN | CT | 06520 | 060646973 | STATE OF CONNECTICUT | $125,000 | $0 | SUBAWARD |
| UNIVERSITY OF ARIZONA | ||||||||
| PO BOX 41867 | TUCSON | AZ | 85717 | 742652689 | STATE OF ARIZONA | $108,444 | $0 | SUBAWARD |
| EVIDERA INC | ||||||||
| 7101 WISCONSIN AVENUE SUITE | BETHESDA | MD | 20814 | 541759539 | STATE OF MARYLAND | $23,877 | $0 | SUBAWARD |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 9 | Total501c3OrgCnt |
| Total Other Org | 12 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | CRITICAL PATH INSTITUTE ENTERS INTO SUBAWARD AGREEMENTS WITH SUBRECIPIENTS AND REVIEWS PROGRESS DELIVERABLES AND COSTS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MS KRISTEN SWINGLE | ||||||||||||||
| COO & PRESIDENT | $288,447 | $0 | $21,700 | $0 | $0 | $0 | $21,814 | $0 | $24,504 | $0 | $356,465 | $0 | $0 | $0 |
| DR KLAUS ROMERO | ||||||||||||||
| CHIEF SCIENCE OFFICER | $237,099 | $0 | $4,700 | $0 | $0 | $0 | $19,482 | $0 | $15,508 | $0 | $276,789 | $0 | $0 | $0 |
| MR KEVIN PERKINS | ||||||||||||||
| CHIEF FINANCIAL OFFICER & TREASURER | $220,067 | $0 | $16,875 | $0 | $0 | $0 | $19,710 | $0 | $28,104 | $0 | $284,756 | $0 | $0 | $0 |
| MR RICHARD LIWSKI | ||||||||||||||
| CHIEF TECHNOLOGY OFFICER | $213,419 | $0 | $12,731 | $0 | $0 | $0 | $18,049 | $0 | $11,554 | $0 | $255,753 | $0 | $0 | $0 |
| DR STEPHEN COONS | ||||||||||||||
| SENIOR VICE PRESIDENT THRU 03/31/23 | $219,841 | $0 | $4,326 | $0 | $0 | $0 | $17,931 | $0 | $11,028 | $0 | $253,126 | $0 | $0 | $0 |
| DR SUDHIR SIVAKUMARAN | ||||||||||||||
| VICE PRESIDENT/EXECUTIVE DIRECTOR | $204,618 | $0 | $4,201 | $0 | $0 | $0 | $17,415 | $0 | $22,383 | $0 | $248,617 | $0 | $0 | $0 |
| DR DIANE STEPHENSON | ||||||||||||||
| EXECUTIVE DIRECTOR | $190,519 | $0 | $3,763 | $0 | $0 | $0 | $14,727 | $0 | $15,948 | $0 | $224,957 | $0 | $0 | $0 |
| DR SERGEY RAKHILIN | ||||||||||||||
| EXECUTIVE DIRECTOR | $188,854 | $0 | $1,520 | $0 | $0 | $0 | $11,804 | $0 | $636 | $0 | $202,814 | $0 | $0 | $0 |
| MS SONYA EREMENCO | ||||||||||||||
| EXECUTIVE DIRECTOR | $186,627 | $0 | $3,740 | $0 | $0 | $0 | $15,558 | $0 | $11,797 | $0 | $217,722 | $0 | $0 | $0 |
| DR MARCO SCHITO | ||||||||||||||
| EXECUTIVE DIRECTOR | $178,495 | $0 | $3,530 | $0 | $0 | $0 | $14,632 | $0 | $15,150 | $0 | $211,807 | $0 | $0 | $0 |
| MS TERINA MARTINEZ | ||||||||||||||
| EXECUTIVE DIRECTOR | $178,513 | $0 | $3,500 | $0 | $0 | $0 | $14,560 | $0 | $7,229 | $0 | $203,802 | $0 | $0 | $0 |
| DR KANWALJIT SINGH | ||||||||||||||
| EXECUTIVE DIRECTOR | $174,890 | $0 | $3,523 | $0 | $0 | $0 | $11,597 | $0 | $23,363 | $0 | $213,373 | $0 | $0 | $0 |
| MR NICHOLAS KING | ||||||||||||||
| EXECUTIVE DIRECTOR | $169,681 | $0 | $3,400 | $0 | $0 | $0 | $14,093 | $0 | $10,450 | $0 | $197,624 | $0 | $0 | $0 |
| MR LEWIS BARBIERI | ||||||||||||||
| CORPORATE SECRETARY | $130,896 | $0 | $3,537 | $0 | $0 | $0 | $10,846 | $0 | $13,165 | $0 | $158,444 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 7 | FormAndLineReferenceDesc |
| Explanation | CRITICAL PATH AWARDS VARIABLE COMPENSATION BASED ON PERFORMANCE AND WITH GUIDANCE FROM THE COMPENSATION COMMITTEE. | ExplanationTxt |
Schedule M IRS990ScheduleM
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | OFFICE FURNITURE | Desc |
| Contribution | 1 | ContributionCnt |
| Noncash Contributions Rpt F990 | $32,192 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | THRIFT SALE VALUE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, COLUMN (B): | FormAndLineReferenceDesc |
| Explanation | THE AMOUNT IN COLUMN B REPRESENTS THE NUMBER OF CONTRIBUTIONS. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (9 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICES | RDCA-DAP IS AN FDA-FUNDED INITIATIVE THAT WILL PROVIDE A CENTRALIZED AND STANDARDIZED INFRASTRUCTURE TO SUPPORT AND ACCELERATE RARE DISEASE CHARACTERIZATION WITH THE GOAL OF ACCELERATING THERAPY DEVELOPMENT. 2023 PROVED TO BE A BANNER YEAR FOR THE PLATFORM. THE PAST YEAR SAW 15 DISEASE DATA SETS ADDED TO THE PLATFORM TO MAKE IT 73 RARE DISEASE DATA SETS OVERALL, REPRESENTING OVER 34 DISEASE STATES (15 DISEASES ADDED IN 2023). THERE ARE NOW 445 PLATFORM USERS AND 26 ACTIVE WORKSPACES. ACTIVE AGREEMENTS NOW INCLUDE 35 DATA CONTRIBUTION AGREEMENTS, EIGHT NORD DATA CONTRIBUTION COVERSHEETS AND FOUR TASK FORCE AGREEMENTS. THERE WERE CONTINUED ADVANCEMENTS IN DATA AGGREGATION AND DISEASE MODELING IN THE DISEASE AREAS OF FRIEDREICH'S ATAXIA (FA) AND PROGRESSIVE SUPRANUCLEAR PALSY, AS WELL AS THE ESTABLISHMENT OF A CLINICAL TRIAL SIMULATOR TO INFORM TRIAL DESIGN IN FA. THIS YEAR ALSO MARKED THE RELEASE OF CRITICAL PATH ONTOLOGY (CPONT) APPLICATION, WHICH FACILITATES MAPPING AND LINKING BETWEEN DIFFERENT STANDARDIZED DATA VOCABULARIES. THERE WAS ALSO A SIGNIFICANT PAPER PUBLICATION, "THE FUTURE OF RARE DISEASE DRUG DEVELOPMENT: THE RARE DISEASE CURES ACCELERATOR DATA ANALYTICS PLATFORM (RDCA-DAP)" IN THE JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS. ANOTHER SIGNIFICANT PUBLICATION WAS THAT OF EDUCATION MODULES 1-3. "RARE DISEASE DRUG DEVELOPMENT: WHAT PATIENTS AND ADVOCATES NEED TO KNOW." RDCA-DAP MADE SIGNIFICANT CONTRIBUTIONS TO THE COMMUNITY IN PERSON; THE 2023 RARE AND ORPHAN DISEASE CONFERENCE HAD 282 REGISTRANTS AND 202 ATTENDEES, INCLUDING 53 EXTERNAL SPEAKERS AND PANELISTS ACROSS ACADEMIA, GOVERNMENT/REGULATORY, INDUSTRY, NONPROFITS, AND PATIENTS/CAREGIVERS. LASTLY, THE PROGRAM MADE A SIGNIFICANT IMPACT ON PROFESSIONAL DEVELOPMENT WITH FOUR WEBINARS HELD AS PART OF ITS PROFESSIONAL DEVELOPMENT SERIES, WITH 760 REGISTRANTS AND 441 ATTENDEES. |
| FORM 990, PART III, LINE 4B, DESCRIPTION OF PROGRAM SERVICES | CURE DRUG REPURPOSING COLLABORATORY (CDRC) WAS FOUNDED IN 2020 AND IS DESIGNED TO CAPTURE REAL-WORLD CLINICAL OUTCOME DATA TO ADVANCE DRUG REPURPOSING AND INFORM FUTURE CLINICAL TRIALS FOR DISEASES OF HIGH UNMET MEDICAL NEED. THE PAST YEAR REPRESENTED SOME INCREDIBLE PROGRESS FROM THE COLLABORATORY. CDRC ASSISTED IN THE DEVELOPMENT, CONSENSUS, FINALIZATION, AND DEPLOYMENT OF A SARCOMA CLINICAL CASE REPORT FORM FOR THE CURE ID APP WITH INPUT FROM MULTIPLE STAKEHOLDERS, AND ALSO INITIATED A CONTRACT WITH PROGRAM PARTNER XCURES TO EXTRACT DATA FROM SARCOMA PATIENT EHRS FOR PECOMA CASES. STUDENTS FROM CLEMSON UNIVERSITY SCHOOL OF MEDICINE AND INTERNS FROM CDRC ALSO HAD THE OPPORTUNITY TO EXTRACT PECOMA CASES FROM THE LITERATURE TO CURE ID, WHILE THE PROGRAM ESTABLISHED AND LED MONTHLY SARCOMA WORKGROUP CALLS FOR PATIENTS, CLINICIANS, AND FDA OCE (ONCOLOGY CENTERS OF EXCELLENCE) TO DEVELOP A SARCOMA PILOT WITHIN CURE ID. CDRC PARTNERED WITH HEHEALTH TO REVIEW AND EDIT THE MPOX CRF ON CURE ID APP TO PROMOTE OUTREACH TO PATIENTS. THE TEAM CREATED AN INTERNATIONAL STI SURVEILLANCE GROUP UNDER THE AUSPICES OF WHO, WITH EXISTING SURVEILLANCE EFFORTS IN THE U.S., CANADA, AND THE UK TO PARTNER ON A PROJECT TO IDENTIFY REPURPOSED DRUGS FOR NEISSERIA GONORRHEA WITH ADDITIONAL COUNTRIES AS OBSERVERS. THIS GROUP HELPED CREATE THE CRF FOR NEISSERIA GONORRHEA AND ORGANIZED A MONTHLY LONG COVID CLINICAL THINK TANK CALL SERIES CONSISTING OF 27 CLINICAL TRIALISTS REGULATORS, ACADEMICIANS AND FOUNDATIONS ACROSS THE U.S., CANADA, AND EUROPE TO REVIEW AND DISCUSS CHALLENGES IN SETTING UP AND DESIGNING CLINICAL TRIALS FOR THIS DISEASE. |
| FORM 990, PART III, LINE 4C, DESCRIPTION OF PROGRAM SERVICES | CP-RND WAS FOUNDED IN SEPTEMBER 2022 TO LEAD COLLABORATIONS THAT ADVANCE TREATMENTS TO IMPROVE THE LIVES OF THOSE AFFECTED BY RARE NEURODEGENERATIVE DISEASES, INCLUDING ALS. CP-RND HAD MAJOR HIGHLIGHTS IN ITS FIRST FULL YEAR AS A C-PATH CONSORTIUM. IN REGARD TO ITS PATIENT-FOCUSED DRUG DEVELOPMENT PROCESS, THE GROUP WAS ACTIVE IN ITS ENGAGEMENT WITH PEOPLE LIVING WITH DISEASES, ITS COORDINATION WITH ACCELERATING MEDICINE PARTNERSHIP (AMP) EFFORTS, AND IN THE FORMATION OF A PEOPLE WITH LIVED EXPERIENCES (PWLE) GROUP TO GIVE AND RECEIVE FEEDBACK ON ALS-RELATED PROJECTS. FROM A DATA PERSPECTIVE, CP-RND REVIEWED OVER 70 LARGE DATABASES, WITH A PRIORITY LISTING CREATED AND SHARED WITH AMP ALS. THE GROUP ALSO SUMMARIZED RESULTS OF AROUND 700 STUDIES FROM CLINICALTRIALS.GOV SEARCHES. PROGRESS FOR DATA DICTIONARY COLLECTION AND DATA SHARE AGREEMENTS REMAIN ONGOING. FINALLY, CP-RND'S SCIENTIFIC CONTRIBUTIONS ARE REFLECTED BY ITS EFFORTS TO REVIEW AND COLLABORATE WITH KEY OPINION LEADERS REGARDING NFL/TDP43 AND OTHER POTENTIAL BIOMARKERS FOR USE IN ALS CLINICAL TRIALS. |
| FORM 990, PART VI, SECTION A, LINE 2 | JEFF JACOB AND SHAUN KIRKPATRICK HAVE A BUSINESS RELATIONSHIP. |
| FORM 990, PART VI, SECTION B, LINE 11B | FORM 990 IS PREPARED BY AN EXTERNAL CPA FIRM USING INFORMATION PROVIDED BY THE ORGANIZATION. THE FORM IS REVIEWED BY THE ORGANIZATION'S CFO, PRESIDENT/COO, CEO, THE BOARD AUDIT, FINANCE, AND RISK COMMITTEE, AND THE BOARD OF DIRECTORS PRIOR TO BEING FINALIZED. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL MEMBERS OF THE BOARD OF DIRECTORS AND ALL OFFICERS OF THE ORGANIZATION ARE REQUIRED TO FILL OUT A CONFLICT OF INTEREST FORM ANNUALLY. THE RESULTS ARE COMPILED AND REVIEWED BY THE BOARD'S AUDIT, FINANCE, AND RISK COMMITTEE. ANY ACTUAL OR PERCEIVED CONFLICTS THAT HAVE THE POTENTIAL TO BIAS ANY DISCUSSIONS OR DECISIONS BY THE BOARD ARE DISCUSSED BY THE BOARD. ANY DIRECTOR WITH A REAL OR POTENTIAL CONFLICT WILL RECUSE THEMSELVES FROM ANY DISCUSSION OR DECISION WHERE THE CONFLICT HAS A BEARING. |
| FORM 990, PART VI, SECTION B, LINE 15 | A BOARD OF DIRECTORS COMPENSATION COMMITTEE MEETS AND REVIEWS EXECUTIVE COMPENSATION ANNUALLY. PERIODICALLY, THE COMMITTEE REQUESTS A COMPENSATION ANALYSIS TO DETERMINE IF EMPLOYEE COMPENSATION HAS REMAINED WITHIN MARKET RANGE OR IF ADJUSTMENTS ARE REQUIRED. THIS INFORMATION IS THEN USED AS A BASIS FOR THE COMPENSATION COMMITTEE'S RECOMMENDATION TO THE BOARD OF DIRECTORS. AN OVERALL SALARY PROGRAM FOR EMPLOYEES MUST BE APPROVED BY THE BOARD OF DIRECTORS COMPENSATION COMMITTEE BEFORE IMPLEMENTATION. ALL EMPLOYEE SALARY INCREASES MUST BE APPROVED BY THE PRESIDENT/COO. |
| FORM 990, PART VI, SECTION C, LINE 19 | ARTICLES OF INCORPORATION CAN BE FOUND ON THE ARIZONA CORPORATION COMMISSION WEBSITE. THE CONFLICT OF INTEREST POLICY AND THE FINANCIAL STATEMENTS (VIA THE ANNUAL REPORT) ARE POSTED ON THE INSTITUTE'S WEBSITE. |
| FORM 990, PART XI, LINE 9: | BOOK/TAX DIFFERENCE - OPERATING LEASE -17,574. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CRITICAL PATH INSTITUTE STICHTING | BusinessNameLine1Txt |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1083 HN AMSTERDAM | AddressLine1Txt |
| City | AMSTERDAM | CityNm |
| Country | NL | CountryCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | EDUCATION AND RESEARCH IN EUROPE TO ACCELERATE DEVELOPMENT OF NEW THERAPIES | PrimaryActivitiesTxt |
| Legal Domicile Foreign Country | NL | LegalDomicileForeignCountryCd |
| Total Income | $0 | TotalIncomeAmt |
| End Of Year Assets | $82,200 | EndOfYearAssetsAmt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CRITICAL PATH INSTITUTE | BusinessNameLine1Txt |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CRITICAL PATH INSTITUTE LTD | BusinessNameLine1Txt |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 33 SIR JOHN ROGERSONS QUAY | AddressLine1Txt |
| City | DUBLIN | CityNm |
| Country | EI | CountryCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | EDUCATION AND RESEARCH IN EUROPE TO ACCELERATE DEVELOPMENT OF NEW THERAPIES | PrimaryActivitiesTxt |
| Legal Domicile Foreign Country | EI | LegalDomicileForeignCountryCd |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CRITICAL PATH INSTITUTE STICHTING | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Entity Type | C | EntityTypeTxt |
| Share Of EOY Assets | $364,512 | ShareOfEOYAssetsAmt |
| Ownership | 1.00000 | OwnershipPct |
| Controlled Organization | Yes (1) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | 0 | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | Yes (1) | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | 0 | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp
Other Organization Name OtherOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CRITICAL PATH INSTITUTE LTD | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transaction Type | D | TransactionTypeTxt |
| Involved | $149,011 | InvolvedAmt |
| Method Of Amount Determination | END OF YEAR BALANCE | MethodOfAmountDeterminationTxt |